T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 28.1 CNY -0.64% Market Closed
Market Cap: 2.3B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tongling Jieya Biologic Technology Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Additional Paid In Capital
ÂĄ1B
CAGR 3-Years
733%
CAGR 5-Years
114%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Additional Paid In Capital
ÂĄ865m
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Additional Paid In Capital
ÂĄ2.8B
CAGR 3-Years
380%
CAGR 5-Years
125%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Additional Paid In Capital
ÂĄ6.1B
CAGR 3-Years
24%
CAGR 5-Years
25%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Additional Paid In Capital
ÂĄ1.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 18%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
1B CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Additional Paid In Capital amounts to 1B CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
114%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Tongling Jieya Biologic Technology Co Ltd have been 733% over the past three years , 114% over the past five years .

Back to Top